Similar trends in serum VEGF-D levels and kidney angiomyolipoma responses with longer duration sirolimus treatment in adults with tuberous sclerosis.
We have previously shown that serum VEGF-D is elevated at baseline, correlates with kidney angiomyolipoma size at baseline and 12 months, and decreases with sirolimus treatment in adults with tuberous sclerosis complex (TSC). To further investigate the utility of serum VEGF-D for longer term monitor...
Main Authors: | Izabela A Malinowska, Nancy Lee, Vidhya Kumar, Elizabeth A Thiele, David Neal Franz, Stephen Ashwal, Arthur Sagalowsky, Francis J Dimario, Drew Cutler, Darcy Krueger, Susana Camposano, Jan Paolini, Sandra L Dabora |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3577773?pdf=render |
Similar Items
-
Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decrease.
by: Sandra L Dabora, et al.
Published: (2011-01-01) -
Everolimus versus sirolimus for angiomyolipoma associated with tuberous sclerosis complex: a multi-institutional retrospective study in China
by: Cong Luo, et al.
Published: (2021-07-01) -
Successful treatment of multiple angiomyolipomas with sirolimus in a child
by: K Pabedinskas, et al.
Published: (2017-01-01) -
Bilateral renal angiomyolipomas in tuberous sclerosis
by: Bushra Jawaid, et al.
Published: (2021-04-01) -
Tuberous Sclerosis or Angiomyolipoma? A Case Report
by: Ana-Maria Pașatu-Cornea, et al.
Published: (2021-08-01)